Abstract
Background: High-grade (HG) mucinous appendiceal neoplasms (MAN) have a worse prognosis than low-grade histology. Our objective was to assess the safety and efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS/HIPEC) in patients with high-grade, high-volume (HG–HV) peritoneal metastases in whom the utility of this aggressive approach is controversial. Methods: Prospectively collected perioperative data were compared between patients with peritoneal metastases from HG–HV MAN, defined as simplified peritoneal cancer index (SPCI) ≥12, and those with high-grade, low-volume (HG–LV; SPCI
Original language | English (US) |
---|---|
Pages (from-to) | 382-390 |
Number of pages | 9 |
Journal | Annals of Surgical Oncology |
Volume | 23 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2016 |
ASJC Scopus subject areas
- Surgery
- Oncology